Physical characteristics, blood hormone concentrations, and plasma lipid concentrations in obese horses with insulin resistance

Journal of the American Veterinary Medical Association

Volumn 228, Issue 9, 2006, Pages 1383-1390

  Frank, Nicholas ^a   Elliott, Sarah B ^a   Brandt, Laura E ^a   Keisler, Duane H ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LEPTIN; LIPID; VERY LOW DENSITY LIPOPROTEIN;

ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORSE DISEASE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NECK CIRCUMFERENCE; NONHUMAN; OBESITY; PHYSICAL EXAMINATION;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; FEMALE; HORMONES; HORSE DISEASES; HORSES; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; LIPIDS; MALE; OBESITY;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 33646230549     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.228.9.1383     Document Type: Article

References (50)

1. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004;89:2601-2607.
2. Hoffman RM, Boston RC, Stefanovski D, et al. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J Anim Sci 2003;81:2333-2342.
3. Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? Equine Vet J Suppl 1998:133-138.
4. Coffman JR, Colles CM. Insulin tolerance in laminitic ponies. Can J Comp Med 1983;47:347-351.
5. Jeffcott LB, Field JR, McLean JG, et al. Glucose tolerance and insulin sensitivity in ponies and Standardbred horses. Equine Vet J 1986;18:97-101.
6. Donaldson MT, Jorgensen AJ, Beech J. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc 2004;224:1123-1127.
7. Garcia MC, Beech J. Equine intravenous glucose tolerance test: glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma. Am J Vet Res 1986;47:570-572.
8. Johnson PJ. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract 2002;18:271-293.
9. Kronfeld DS. Equine syndrome X, the metabolic syndrome, and equine grain-associated disorders: nomenclature and dietetics. J Equine Vet Sci 2003;23:567-569.
10. Marchesini G, Forlani G, Cerrelli F, et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med 2004;21:383-387.
11. Freestone JF, Wolfsheimer KJ, Ford RB, et al. Triglyceride, insulin, and cortisol responses of ponies to fasting and dexamethasone administration. J Vet Intern Med 1991;5:15-22.
12. Forhead AJ, French J, Ikin P, et al. Relationship between plasma insulin and triglyceride concentrations in hypertriglyceridaemic donkeys. Res Vet Sci 1994;56:389-392.
13. Kronfeld DS, Treiber KH, Geor RJ. Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies. J Am Vet Med Assoc 2005;226:712-719.
14. Eiler H, Frank N, Andrews FM, et al. Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses. Am J Vet Res 2005;66:1598-1604.
15. Henneke DR, Potter GD, Kreider JL, et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983;15:371-372.
16. Eiler H, Oliver JW, Andrews FM, et al. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma. J Am Vet Med Assoc 1997;211:79-81.
17. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
18. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Polin phenol reagent. J Biol Chem 1951;193:265-275.
19. Markwell MA, Haas SM, Bieber LL, et al. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978;87:206-210.
20. Watson TD, Burns L, Love S, et al. The isolation, characterisation and quantification of the equine plasma lipoproteins. Equine Vet J 1991;23:353-359.
21. Freestone JF, Wolfsheimer KJ, Kamerling SG, et al. Exercise induced hormonal and metabolic changes in Thoroughbred horses: effects of conditioning and acepromazine. Equine Vet J 1991;23:219-223.
22. Buff PR, Dodds AC, Morrison CD, et al. Leptin in horses: tissue localization and relationship between peripheral concentrations of leptin and body condition. J Anim Sci 2002;80:2942-2948.
23. McFarlane D, Beech J, Cribb A. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants. Domest Anim Endocrinol 2005;in press.
24. Robie SM, Janson CH, Smith SC, et al. Equine serum lipids: serum lipids and glucose in Morgan and Thoroughbred horses and Shetland ponies. Am J Vet Res 1975;36:1705-1708.
25. Zicker SC, Brumbaugh GW. Effects of phenylbutazone on glucose tolerance and on secretion of insulin in healthy geldings. Am J Vet Res 1989;50:743-746.
26. Kearns CF, McKeever KH, Abe T. Overview of horse body composition and muscle architecture: implications for performance. Vet J 2002;164:224-234.
27. Donaldson MT, McFarlane D, Jorgensen AJ, et al. Correlation between plasma alpha-melanocyte-stimulating hormone concentration and body mass index in healthy horses. Am J Vet Res 2004;65:1469-1473.
28. Forro M, Cieslar S, Ecker GL, et al. Total body water and ECFV measured using bioelectrical impedance analysis and indicator dilution in horses. J Appl Physiol 2000;89:663-671.
29. Kearns CF, McKeever KH, Kumagai K, et al. Fat-free mass is related to one-mile race performance in elite standardbred horses. Vet J 2002;163:260-266.
30. Reaven GM. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals. Endocrinol Metab Clin North Am 2005;34:49-62.
31. Geor RJ, Hinchcliff KW, McCutcheon LJ, et al. Epinephrine inhibits exogenous glucose utilization in exercising horses. J Appl Physiol 2000;88:1777-1790.
32. Cartmill JA, Thompson DL Jr, Storer WA, et al. Endocrine responses in mares and geldings with high body condition scores grouped by high vs. low resting leptin concentrations. J Anim Sci 2003;81:2311-2321.
33. Forhead AJ, Smart D, Smith RF, et al. Transport-induced stress responses in fed and fasted donkeys. Res Vet Sci 1995;58:144-151.
34. Kronfeld D, Rodiek A, Stull C. Glycemic indices, glycemic loads, and glycemic dietetics. J Equine Vet Sci 2004;24:399-404.
35. Frank N, Andrews FM, Elliott SB, et al. Effects of rice bran oil on plasma lipid concentrations, lipoprotein composition, and glucose dynamics in mares. J Anim Sci 2005;83:2509-2518.
36. Fitzgerald BP, Reedy SE, Sessions DR, et al. Potential signals mediating the maintenance of reproductive activity during the non-breeding season of the mare. Reprod Suppl 2002;59:115-129.
37. Powell DM, Reedy SE, Sessions DR, et al. Effect of short-term exercise training on insulin sensitivity in obese and lean mares. Equine Vet J Suppl 2002;34:81-84.
38. Hawley JA. Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 2004;20:383-393.
39. Boden G, Laakso M. Lipids and glucose in type 2 diabetes: what is the cause and effect? Diabetes Care 2004;27:2253-2259.
40. Poitout V1 Robertson RP. Minireview: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity Endocrinology 2002;143:339-342.
41. Frank N, Sojka JE, Latour MA. Effects of hypothyroidism and withholding of feed on plasma lipid concentrations, concentration and composition of very-low-density lipoprotein, and plasma lipase activity in horses. Am J Vet Res 2003;64:823-828.
42. Frank N, Sommardahl CS, Eiler H, et al. Effects of oral administration of levothyroxine sodium on concentrations of plasma lipids, concentration and composition of very-low-density lipoproteins, and glucose dynamics in healthy adult mares. Am J Vet Res 2005;66:1032-1038.
43. Watson TD, Burns L, Love S, et al. Plasma lipids, lipoproteins and post-heparin lipases in ponies with hyperlipaemia. Equine Vet J 1992;24:341-346.
44. Watson TD, Burns L, Freeman DJ, et al. High density lipoprotein metabolism in the horse (Equus caballus). Comp Biochem Physiol B 1993;104:45-53.
45. Watson TD, Packard CJ, Shepherd J. Plasma lipid transport in the horse (Equus caballus). Comp Biochem Physiol B 1993;106: 27-34.
46. Geelen SN, Jansen WL, van Oldruitenborgh-Oosterbaan MM, et al. Fat feeding increases equine heparin-released lipoprotein lipase activity. J Vet Intern Med 2001;15:478-481.
47. Buff PR, Morrison CD, Ganjam VK, et al. Effects of short-term feed deprivation and melatonin implants on circadian patterns of leptin in the horse J Anim Sci 2005;83:1023-1032.
48. Gordon ME, McKeever KH. Diurnal variation of ghrelin, leptin, and adiponectin in Standardbred mares. J Anim Sci 2005; 83:2365-2371.
49. Fitzgerald BP, McManus CJ. Photoperiodic versus metabolic signals as determinants of seasonal anestrus in the mare. Biol Reprod 2000;63:335-340.
50. Donaldson MT, McDonnell SM, Schanbacher BJ, et al. Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses. J Vet Intern Med 2005;19:217-222.